CVS to close ‘select’ pharmacies in Target stores in the coming months

CVS to close ‘select’ pharmacies in Target stores in the coming months


CVS to close 'select' pharmacies in Target stores starting in February

CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle to boost profits. 

The closures will begin in February and finish by the end of April, the spokesperson said in a statement. She added that employees affected by the closures will be offered comparable roles within CVS, and prescriptions will be transferred to a nearby CVS pharmacy before a location closes.

The spokesperson did not disclose how many stores would be shuttered, but a report from The Wall Street Journal on Thursday said CVS would close “dozens” of locations.

CVS operates 9,000 pharmacy locations nationwide. The company has a pharmacy in about 1,800 of Target’s 1,956 stores in the U.S., according to a Target spokesperson. 

The Target spokesperson declined to comment on the closures or share plans for the closed CVS locations. 

The decision to shutter the stores is part of CVS’ effort to reduce its retail footprint “based on our evaluation of changes in population, consumer buying patterns and future health needs,” the CVS spokesperson said.

In 2021, CVS said it would close about 900 stores, which is about 10% of its U.S. locations, between 2022 and 2024, as the company pushes to transform itself from a major drugstore chain into a large health-care company.

CVS has deepened that push over the past year with its nearly $8 billion acquisition of health-care provider Signify Health and $10.6 billion deal to buy Oak Street Health, which operates primary care clinics for seniors.

But the company also launched a cost-cutting program last year as part of that expensive push into health care, with plans to lay off 5,000 employees.

The closures also come after pharmacy staff from CVS and other drugstore chains walked out in the fall to protest what they call harsh working conditions that put both employees and patients at risk. CVS has told CNBC that the company is engaging with staff to directly address any concerns they might have.

— CNBC’s Melissa Repko contributed to this report.

Don’t miss these stories from CNBC PRO:



Source

Healthy Returns: What to know about a CDC vaccine panel’s votes against a mercury preservative in flu shots
Health

Healthy Returns: What to know about a CDC vaccine panel’s votes against a mercury preservative in flu shots

Biostatistician and epidemiologist Martin Kulldorff, MD, PhD, and Dr. Mina Zadeh, ACIP Executive Secretary, CDC, look on as people present their information to members of the Advisory Committee on Immunization Practices, as the U.S. Centers for Disease Control and Prevention’s (CDC) advisory panel for vaccines convenes, in Atlanta, Georgia, U.S. June 25, 2025. Megan Varner […]

Read More
Medicaid cuts in Trump’s ‘big beautiful’ bill will leave millions uninsured, threaten rural hospitals
Health

Medicaid cuts in Trump’s ‘big beautiful’ bill will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump’s “big, beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide […]

Read More
Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Health

Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and […]

Read More